Bristol BioDesign Institute - BrisSynBio - Flexible Talent Mobility Account
Lead Research Organisation:
University of Bristol
Department Name: Biochemistry
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
People |
ORCID iD |
| Imre Berger (Principal Investigator) |
| Description | The two BioDesign Innovation Fellowships have underpinned the formation of two new SynBio start-ups: Phase Biolabs and Mechanised Biosystems Seven Early Career Researchers have benefitted from secondments in synthetic biology SMEs or in pre-spin out synthetic biology projects, three of whom have been recruited to permanent positions by their host SMEs, and one of whom has been recruited to a new synthetic biology SME. The SMEs make a significan contribution to the local economy, collectively raising over £16M and creating more than 50 jobs to date. The impact of the additional funds beyond those of the original award are: 1. An inward Innovation Placement for a researcher who moved from Italy to Bristol to work on commerically relevant research contributig to the spin out of Rosa Biotech, which has raised £750k of angel funding. 2. Outward Innovation Placements that have been instrumental in the growth and development of Bristol-based synthetic biology ecosystem (CytoSeek, Imophoron, Scarlet Therapeutics, Zentraxa). 3. Graduation of two BioDesign Innovation fellows, who between then have encorporated 4 companies (Phase Biolabs, RapiFarm, testbuds.io, and Mechanised Biosystems) 4. Science Entrepreneur Experience training, which trained 11 synthetic biology PhDs and ECRs from Bristol. |
| First Year Of Impact | 2020 |
| Sector | Aerospace, Defence and Marine,Healthcare,Manufacturing, including Industrial Biotechology |
| Impact Types | Societal |
| Description | BrisEngBio: From Synthetic to Engineering Biology at Bristol |
| Amount | £1,517,913 (GBP) |
| Funding ID | BB/W013959/1 |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2022 |
| End | 01/2024 |
| Description | CytoSeek |
| Organisation | CytoSeek |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | ECR |
| Collaborator Contribution | ECR career development and training in a synthetic biology SME |
| Impact | ECR career development and training in a synthetic biology SME |
| Start Year | 2019 |
| Description | Imophoron |
| Organisation | Imophoron Ltd |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | ECR |
| Collaborator Contribution | ECR career development and training in a synthetic biology SME |
| Impact | ECR career development and training in a synthetic biology SME |
| Start Year | 2019 |
| Description | Lab Genius |
| Organisation | LabGenius |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | ECR |
| Collaborator Contribution | ECR career development and training in a synthetic biology SME |
| Impact | ECR career development and training in a synthetic biology SME |
| Start Year | 2019 |
| Description | Rosa Biotech |
| Organisation | Rosa Biotech Limited |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | ECR |
| Collaborator Contribution | ECR career development and training in a synthetic biology SME |
| Impact | ECR career development and training in a synthetic biology SME |
| Start Year | 2019 |
| Description | Zentraxa |
| Organisation | Zentraxa Ltd |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | ECR |
| Collaborator Contribution | ECR career development and training in a synthetic biology SME |
| Impact | ECR career development and training in a synthetic biology SME |
| Start Year | 2019 |
| Company Name | ROSA BIOTECH LIMITED |
| Description | Biosensing and diagnostic |
| Year Established | 2019 |
| Impact | None yet |
| Website | https://www.rosabio.tech/ |
| Company Name | PHASE BIOLABS LTD |
| Description | Carbon recycling platform |
| Year Established | 2020 |
| Impact | To early to say |
| Website | https://www.phasebiolabs.com/ |
| Company Name | CYTOSEEK LIMITED |
| Description | Next generation cell therapies CytoSeek is developing its Artificial Membrane Binding Protein (AMBP) technology to enhance cell therapies for use in tumour therapies. AMBPs, which bind to virtually all cell types, have a modular design that allows rapid prototyping to deliver new functionalities. Currently, we are developing AMBPs that can provide homing, immunomodulation, and/or hypoxia resistance functionality. |
| Year Established | 2017 |
| Impact | None yet |
| Website | https://www.cytoseek.uk/ |
| Company Name | SCARLET THERAPEUTICS LIMITED |
| Description | Novel engineered red blood cell based therapeutics |
| Year Established | 2021 |
| Impact | None yet |
| Company Name | IMOPHORON LIMITED |
| Description | Novel vaccine platform technology company |
| Year Established | 2017 |
| Impact | Press release issued: 7 October 2021 Faster vaccine development could be a step closer thanks to £4 million investment to Imophoron Ltd, a Bristol University biotech start-up developing a novel, next generation rapid-response vaccine platform called ADDomer™. Imophoron will use the investment to bring ADDomer vaccines to clinical stage, initially targeting three viruses, RSV (respiratory syncytial virus), COVID-19, and mosquito-borne Chikungunya. |
| Website | https://www.linkedin.com/company/imophoron-ltd/ |
| Company Name | ZENTRAXA LIMITED |
| Description | Precision engineering of bespoke peptide biomaterials |
| Year Established | 2017 |
| Impact | Applcations in medial and industrial adhesives and personal care. |
| Website | https://zentraxa.com/ |
| Company Name | MECHANISED BIOSYSTEMS LTD |
| Description | Robotics enhanced mushroom growth and production |
| Year Established | 2020 |
| Impact | To early to say |
| Website | https://mechanisedbiosystems.com/ |